Live price temporarily unavailable.
Senseonics Holdings (SENS) is a Health Care company in the Russell 2000. Latest news and coverage below.
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $332.0K | $6.37M | $18.9M | $21.3M | $4.95M | $13.7M | $16.4M | $22.4M | $22.5M | $35.3M |
| Growth (year over year) | +773.7% | +1819.6% | +196.8% | +12.6% | −76.8% | +176.3% | +19.8% | +36.6% | +0.4% | +56.9% |
| Gross profit | −$328.0K | −$3.38M | −$8.15M | −$19.4M | −$17.4M | −$811.0K | $2.73M | $3.09M | $533.0K | $15.8M |
| Gross margin | −98.8% | −53.1% | −43.1% | −91.3% | −350.9% | −5.9% | 16.6% | 13.8% | 2.4% | 44.7% |
| Operating income | −$42.4M | −$56.3M | −$87.6M | −$130.7M | −$79.1M | −$57.2M | −$68.6M | −$75.6M | −$74.8M | −$68.3M |
| Operating margin | −12781.0% | −883.6% | −463.1% | −613.4% | −1598.9% | −418.1% | −418.7% | −337.7% | −333.0% | −193.8% |
| Net income | −$43.9M | −$59.1M | −$94.0M | −$115.5M | −$175.2M | −$302.5M | $142.1M | −$60.4M | −$78.6M | −$69.1M |
| Net margin | −13231.9% | −927.4% | −496.9% | −542.5% | −3539.5% | −2211.9% | 867.2% | −269.7% | −349.8% | −196.0% |
| EPS (diluted) | −$0.49 | −$0.51 | −$0.60 | −$0.61 | −$0.77 | −$0.72 | −$0.11 | −$0.11 | −$2.50 | −$1.66 |
| Balance sheet | ||||||||||
| Cash and equivalents | $13.0M | $16.1M | $136.8M | $95.9M | $18.0M | $33.5M | $35.8M | $75.7M | $74.6M | $40.2M |
| Total assets | $22.3M | $45.9M | $160.0M | $132.8M | $35.9M | $198.9M | $177.7M | $138.2M | $100.4M | $126.3M |
| Total liabilities | $27.1M | $38.7M | $88.7M | $141.4M | $177.2M | $384.5M | $142.6M | $64.8M | $79.3M | $65.2M |
| Long-term debt | — | — | — | $11.8M | $57.2M | $59.8M | $56.4M | $41.2M | $34.7M | $35.6M |
| Shareholders' equity | −$4.88M | $7.27M | $71.3M | −$8.65M | −$144.1M | −$185.5M | −$2.58M | $35.8M | −$16.6M | $61.0M |
| Cash flow | ||||||||||
| Operating cash flow | −$38.0M | −$55.7M | −$90.8M | −$136.0M | −$67.4M | −$56.1M | −$66.3M | −$70.2M | −$60.5M | −$59.1M |
| Capital expenditure | $479.0K | $345.0K | $989.0K | $1.04M | $181.0K | $210.0K | $312.0K | $350.0K | $2.24M | $1.12M |
| Free cash flow | −$38.5M | −$56.1M | −$91.8M | −$137.1M | −$67.6M | −$56.3M | −$66.6M | −$70.5M | −$62.7M | −$60.2M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $4.26M | $8.30M | $6.26M | $6.65M | $8.10M | $14.3M | $11.7M | $14.5M |
| Growth (year over year) | −30.1% | +3.3% | +24.0% | +36.7% | +89.9% | +71.8% | +87.2% | +117.8% |
| Gross profit | −$4.05M | $3.95M | $1.50M | $3.12M | $3.47M | $7.67M | $6.94M | $8.56M |
| Gross margin | −95.0% | 47.6% | 24.1% | 46.9% | 42.8% | 53.8% | 59.3% | 59.1% |
| Operating income | −$22.8M | −$14.3M | −$13.5M | −$14.3M | −$19.6M | −$20.9M | −$31.8M | −$36.0M |
| Operating margin | −535.9% | −172.0% | −215.6% | −215.4% | −242.1% | −146.8% | −271.9% | −248.5% |
| Net income | −$24.0M | −$15.5M | −$14.3M | −$14.5M | −$19.5M | −$20.8M | −$32.3M | −$36.7M |
| Net margin | −562.4% | −186.5% | −227.9% | −218.1% | −241.3% | −146.1% | −276.1% | −253.4% |
| EPS (diluted) | −$0.77 | −$1.67 | −$0.40 | −$0.36 | −$0.43 | −$0.47 | −$0.71 | −$0.63 |
| Balance sheet | ||||||||
| Cash and equivalents | $27.1M | $74.6M | $39.3M | $31.5M | $34.5M | $40.2M | $29.6M | $44.8M |
| Total assets | $96.3M | $100.4M | $87.2M | $150.3M | $139.9M | $126.3M | $102.9M | $176.8M |
| Total liabilities | $75.9M | $79.3M | $52.0M | $55.6M | $61.8M | $65.2M | $68.5M | $86.5M |
| Long-term debt | $34.4M | $34.7M | $35.0M | $35.2M | $35.3M | $35.6M | $35.9M | $55.8M |
| Shareholders' equity | −$17.2M | −$16.6M | $35.2M | $94.7M | $78.2M | $61.0M | $34.3M | $90.3M |
| Cash flow | ||||||||
| Operating cash flow | −$14.8M | −$14.2M | −$16.1M | −$9.27M | −$15.8M | −$18.0M | −$32.0M | −$30.1M |
| Capital expenditure | −$203.0K | $34.0K | $434.0K | $124.0K | $164.0K | $394.0K | $111.0K | $217.0K |
| Free cash flow | −$14.6M | −$14.3M | −$16.5M | −$9.39M | −$16.0M | −$18.4M | −$32.1M | −$30.4M |
From Senseonics Holdings's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning Senseonics Holdings in our feed yet.